[1]周海洋 周宇 王睿△ 周飞 王中兴 孔晓海.结核T细胞与脊柱结核疗效的关系研究[J].中国中医骨伤科杂志,2019,27(04):15-18.
　ZHOU Haiyang ZHOU Yu WANG Rui ZHOU Fei WANG Zhongxing KONG Xiaohai.Study on the Relationship between Tuberculosis T Cells and Curative Effect of Spinal Tuberculosis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2019,27(04):15-18.
点击复制

结核T细胞与脊柱结核疗效的关系研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第27卷
期数:
2019年04期
页码:
15-18
栏目:
临床研究
出版日期:
2019-04-12

文章信息/Info

Title:
Study on the Relationship between Tuberculosis T Cells and Curative Effect of Spinal Tuberculosis
文章编号:
1005-0205(2019)04-0015-04
作者:
周海洋1 周宇1 王睿1△ 周飞1 王中兴1 孔晓海1
1南京中医药大学附属南京市中西医结合医院(南京,210014)
Author(s):
ZHOU Haiyang1 ZHOU Yu1 WANG Rui1 ZHOU Fei1 WANG Zhongxing1 KONG Xiaohai1
1Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Nanjing University of Traditional Chinese Medicine,Nanjing 210014,China.
关键词:
脊柱结核;  结核细胞;  脊柱固定
Keywords:
spinal tuberculosis;  tuberculosis cells;  spinal fixation
分类号:
R529.2
文献标志码:
A
摘要:
目的:观察脊柱结核抗结核治疗效果与结核感染T细胞检测反应强度的关系。方法:选取本院2015年2月至2017年12月住院治疗的脊柱结核病人,按照TB-IGRA检查结果(80～400 pg/mL)纳入试验组,入院常规抗结核治疗2周后根据TB-IGRA复查结果分为A组(下降≥50 pg/mL)和B组(下降<50 pg/mL)。2周后所有患者均行常规手术治疗,术后2周再次复查A,B两组,下降≥50 pg/mL为A1组(A组)和B1组(B组),下降<50 pg/mL为A2组(A组)和B2组(B组)。手术6个月后分别将A1A2两组、B1B2两组及AB两组之间的脊柱植骨融合时间、结核复发率和愈合率进行比较,观察TB-IGRA值与脊柱结核疗效之间的关系。结果:所有患者均获得6个月以上的随访,植骨融合时间比较:A组和B组植骨融合时间为(5.73±1.24)个月和(7.81±1.95)个月,A1组与A2组为(5.04±1.56)个月和(6.85±1.81)个月,B1组与B2组为(7.12±1.72)个月与(8.90±1.42)个月,组间比较差异均有统计学意义(P<0.05)。术后复发率比较:A组复发率为15%,B组为12.5%,A1,A2组及B1,B2组复发率分别为10%,10%及20%,15%,三组差异无统计学意义(P>0.05)。术后治愈率比较:A组,B组治愈率分别为85%,77.5%,A1,A2组,B1及B2组治愈率分别为90%,85%,80%及70%,三组差异均有统计学意义(P<0.05)。结论:脊柱结核抗结核治疗效果与结核感染T细胞检测反应强度有一定的相关性,对于临床抗结核治疗的方案选择和调整具有指导意义。
Abstract:
Objective: To observe the relationship between the anti-tuberculosis effect of spinal tuberculosis and the response intensity of T cells in tuberculosis infection.Methods:Patients with spinal tuberculosis hospitalized in our hospital from February 2015 to December 2017 were enrolled in the experimental group according to the results of TB-IGRA(400 pg/mL≥N≥80 pg/mL).After two weeks of routine anti-tuberculosis treatment, patients were divided into group A(N value decreased more than 50 pg/mL)and group B(N value decreased less than 50 pg/mL)according to the results of TB-IGRA reexamination.Two weeks later, all patients were treated with routine surgery.Two weeks after operation, the N values of A and B groups were re-examined.The N values decreased more than 50 pg/mL in group A1 and B1, and the N values decreased less than 50 pg/mL in group A2 and group B2.Six months after operation, the fusion time, recurrence rate and healing rate of spinal bone graft between A1A2 group, B1B2 group and AB group were compared, and the relationship between TB-IGRA value and curative effect of spinal tuberculosis was observed.Results: All patients were followed up for more than 6 months.The time of bone graft fusion in group A and B was(5.73±1.24)months and(7.81±1.95)months,(5.04±1.56)months and(6.85±1.81)months in group A1 and group A2,(7.12±1.72)months and(8.90±1.42)months in group B1 and group B2,with P<0.05 in each group.The recurrence rate was 15% in group A and 12.5% in group B.The recurrence rates in group A1, A2, B1 and B2 were 10%, 10%, 20% and 15%.This three groups was no significant difference.Last, the cure rates of group A and B, A1 and A2, B1 and B2 were 85% and 77.5%,90% and 85%, 80% and 70%.Which also had significant differences among this three groups(P<0.05).Conclusion:The therapeutic effect of anti-tuberculosis treatment of spinal tuberculosis is correlated with the response intensity of T cell detection of tuberculosis infection, which is of guiding significance for the selection and adjustment of clinical anti-tuberculosis treatment.

参考文献/References:

[1] HSU H,LACEY D L,DUNSTAN C R,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand[J].Proc Natl Acad Sci USA,1999,96(7):3540-3545.
[2] 陈敬,董德琼,杨渝洁,等.白细胞介素12对结核病患者Th1/Th2平衡的影响[J].中华结核和呼吸杂志,2002,25(5):292-295.
[3] 马恩波,马福云,赵俊才.脊柱结核诊断和外科治疗的研究进展[J].青海医药杂志,2016,46(1):78-79.
[4] 王自立,金卫东,乔永东,等.超短程化疗方案及病变椎体部分切除术治疗脊柱结核[J].中华骨科杂志,2005,25(2):79-85.
[5] 袁凯,吴雪琼,张强,等.结核杆菌抗原特异性丫干扰素释放试验在脊柱结核辅助诊断中的应用研究[J].实用医学杂志,2013,29(14):2314-2316.
[6] KIM S H,SONG K H,CHOI S J,et al.Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients[J].AM J Med,2009,122(2):189-195.
[7] 林淑娴,杨芳芳,彭毅,等.酶联免疫斑点法对抗结核治疗期肺结核患者多肽特异性IFN-γ的检测[J].中国医药生物技术,2013,8(2):93-99.
[8] LEE Y M,KIM S M,PARK S J,et al.Indeterminate T-SPOT.TB test results in patients with suspected extrapulmonary tuberculosis in routine clinical practice[J].Infec Chemother,2013,45(1):44-50.
[9] 施宗祥,朱德智,张少华,等.脊柱结核病灶清除和植骨融合术后复发的影响因素[J].骨科,2013,4(1):11-15,18.
[10] 李宁,艾继超.后路病灶清除、椎间植骨、钉棒内固定治疗胸腰段脊柱结核的临床疗效分析[J].医学综述,2018,24(7):1140-1143.
[11] 汪卫,周永强,王勇平.前路病灶清除植骨内固定与后路内固定治疗多节段胸腰椎椎体结核的疗效对比分析[J].生物骨科材料与临床研究,2016,13(3):38-41.
[12] 王自立,杨伟宇,金卫东,等.病变椎体部分切除、髂骨植骨及内固定术治疗脊柱结核[J].中国脊柱脊髓杂志,2004,14(12):716-719.
[13] LI J H,ZHANG Z H,SHI T,et al.Surgical treatment of lumbosacral tuberculosis by one-stage debridement and anterior instrumentation with allograft through an extraperitoneal anterior approach[J].J Orthop Surg Res,2015,10(1):62.
[14] SONG J F,JING Z Z,CHEN B,et al.One-stage anterolateral surgical treatment for lumbosacral segment tuberculosis[J].Int Orthop,2012,36(2):339-344.
[15] 张少俊,杨驰,范琳.血清结核抗体诊断活动性结核病的价值[J].中国防痨杂志,2018,41(1):20-25.
[16] 梁利川,赵晨,罗磊,等.术后复发性胸腰椎结核的病例特点及临床意义[J].实用骨科杂志,2018,24(7):581-583.
[17] 任涛,张敏,张艺,等.活动性肺结核T细胞亚群分布特点[J].中国防痨杂志,2005,27(1):63-64.

备注/Memo

备注/Memo:
基金项目:2016年南京市科技发展计划项目(201605057) △通信作者 E-mail:wangrui_217@hotmail.com
更新日期/Last Update: 2019-04-12